1.Analysis of SUOX gene variants and clinical features in a child with Isolated sulfite oxidase deficiency.
Chinese Journal of Medical Genetics 2023;40(2):177-180
OBJECTIVE:
To explore the clinical features and genetic basis for a child with early-onset Isolated sulfite oxidase deficiency (ISOD).
METHODS:
A child with ISOD who was admitted to Weihai Hospital Affiliated to Qingdao University on May 10, 2020 was selected as the study subject. Clinical data of the child was analyzed. The child and her parents were subjected to trio-whole exome sequencing, and candidate variants were verified by Sanger sequencing.
RESULTS:
The female neonate was transferred to the intensive care unit due to "secondary pollution of amniotic fluid and laborious breathing for 11 minutes", and had developed frequent convulsions. Genetic testing revealed that she has harbored c.1200C>G and c.188G>A compound heterozygous variants of the SUOX gene, which were inherited from her mother and father, respectively. The c.1200C>G has been described previously and was rated as pathogenic based on guidelines from the American College of Medical Genetics and Genomics, whilst the c.188G>A variant was unreported previously and rated as variant of unknown significance.
CONCLUSION
The compound heterozygous variants of the SUOX gene probably underlay the ISOD in this child. Above finding has enriched the spectrum of SUOX gene variants and provided a basis for the clinical diagnosis and genetic counseling.
Female
;
Humans
;
Infant, Newborn
;
Amino Acid Metabolism, Inborn Errors/diagnosis*
;
Genetic Counseling
;
Genetic Testing
;
Mutation
;
Oxidoreductases Acting on Sulfur Group Donors/genetics*
;
Sulfite Oxidase/genetics*
2.Analysis of ETFDH gene variation in a Chinese family affected with lipid storage myopathy.
Chinese Journal of Medical Genetics 2019;36(10):1002-1005
OBJECTIVE:
To detect potential variation in an ethnic Han Chinese family affected with late-onset lipid storage myopathy.
METHODS:
Next generation sequencing (NGS) was used to screen disease-related genes in the proband. Suspected mutation was validated with PCR and Sanger sequencing in two patients, their father, and 100 healthy controls.
RESULTS:
Heterozygous c.770A>G (p.Tyr257Cys) and c.1395dupT (p.Gly466Tryfs) mutation were detected in the two patients. Their father was found to be heterozygous for the c.770A>G (p.Tyr257Cys) mutation, while the c.1395dupT (p.Gly466Tryfs) variation was not reported previously and not found among the healthy controls.
CONCLUSION
Mutations of the ETFDH gene probably underlie the pathogenesis in this family. The novel c.1395dupT (p.Gly466Tryfs) has enriched the mutation spectrum of EDFDH gene.
Asian Continental Ancestry Group
;
Electron-Transferring Flavoproteins
;
genetics
;
Heterozygote
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Iron-Sulfur Proteins
;
genetics
;
Lipid Metabolism, Inborn Errors
;
genetics
;
Muscular Dystrophies
;
genetics
;
Mutation
;
Oxidoreductases Acting on CH-NH Group Donors
;
genetics
3.Mutation analysis for a family affected with riboflavin responsive-multiple acyl-CoA dehydrogenase deficiency.
Chinese Journal of Medical Genetics 2014;31(4):428-432
OBJECTIVETo identify pathogenic mutation in a boy affected with riboflavin responsive-multiple acyl-CoA dehydrogenase deficiency (RR-MADD).
METHODSThe patient was initially diagnosed as primary carnitine deficiency (PCD) and has been treated with carnitine supplementation for 7 years. Clinical manifestations and characteristics of fibula muscle specimen were analyzed. Potential mutation in electron transfer flavoprotein dehydrogenase (ETFDH) gene (for the patient and his parents) and carnitine transfer protein gene (SLC22A5) (for the patient) was screened.
RESULTSElectronic microscopy of the muscle specimen has suggested lipid storage myopathy. Mutation analysis has found that the patient carried compound heterozygous mutations, c.250G>A and c.380T>C, in exon 3 of the ETFDH gene, whilst his father and mother were heterozygous for the c.380T>C and c.250G>A mutations, respectively. Screening of the SLC22A5 gene has yielded no clinically meaningful result. After the establishment of diagnosis of RR-MADD, the condition of the patient has improved greatly with supplementation of high doses of riboflavin along with continuous carnitine supplement.
CONCLUSIONThe c.250G>A (p.Ala84Thr) mutation of exon 3 of the ETFDH gene has been a hot spot in Southern Chinese population, whilst the c.380T>C (p.Leu127Pro) is rarely reported. Our case has suggested that therapeutic diagnosis cannot substitute genetic testing. The mechanism for having stabilized the patient with only carnitine supplementation for 7 years needs further investigation.
Adolescent ; Adult ; Base Sequence ; Child ; DNA Mutational Analysis ; Electron-Transferring Flavoproteins ; genetics ; metabolism ; Female ; Humans ; Iron-Sulfur Proteins ; genetics ; metabolism ; Male ; Molecular Sequence Data ; Multiple Acyl Coenzyme A Dehydrogenase Deficiency ; enzymology ; genetics ; metabolism ; Muscle, Skeletal ; metabolism ; Organic Cation Transport Proteins ; genetics ; metabolism ; Oxidoreductases Acting on CH-NH Group Donors ; genetics ; metabolism ; Riboflavin ; metabolism ; Solute Carrier Family 22 Member 5
4.Clinical and muscle magnetic resonance image findings in patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
Dao-Jun HONG ; Min ZHU ; Zi-Juan ZHU ; Lu CONG ; Shan-Shan ZHONG ; Ling LIU ; Jun ZHANG
Chinese Medical Journal 2019;132(3):275-284
BACKGROUND:
Late-onset multiple acyl-coA dehydrogenase deficiency (MADD) is an autosomal recessive inherited metabolic disorder. It is still unclear about the muscle magnetic resonance image (MRI) pattern of the distal lower limb pre- and post-treatment in patients with late-onset MADD. This study described the clinical and genetic findings in a cohort of patients with late-onset MADD, and aimed to characterize the MRI pattern of the lower limbs.
METHODS:
Clinical data were retrospectively collected from clinic centers of Peking University People's Hospital between February 2014 and February 2018. Muscle biopsy, blood acylcarnitines, and urine organic acids profiles, and genetic analysis were conducted to establish the diagnosis of MADD in 25 patients. Muscle MRI of the thigh and leg were performed in all patients before treatment. Eight patients received MRI re-examinations after treatment.
RESULTS:
All patients presented with muscle weakness or exercise intolerance associated with variants in the electron transfer flavoprotein dehydrogenase gene. Muscle MRI showed a sign of both edema-like change and fat infiltration selectively involving in the soleus (SO) but sparing of the gastrocnemius (GA) in the leg. Similar sign of selective involvement of the biceps femoris longus (BFL) but sparing of the semitendinosus (ST) was observed in the thigh. The sensitivity and specificity of the combination of either "SO+/GA-" sign or "BFL+/ST-" sign for the diagnosis of late-onset MADD were 80.0% and 83.5%, respectively. Logistic regression model supported the findings. The edema-like change in the SO and BFL muscles were quickly recovered at 1 month after treatment, and the clinical symptom was also relieved.
CONCLUSIONS
This study expands the clinical and genetic spectrums of late-onset MADD. Muscle MRI shows a distinct pattern in the lower limb of patients with late-onset MADD. The dynamic change of edema-like change in the affected muscles might be a potential biomarker of treatment response.
Adolescent
;
Adult
;
Biopsy
;
methods
;
Carnitine
;
analogs & derivatives
;
blood
;
Electron-Transferring Flavoproteins
;
genetics
;
Female
;
Hamstring Muscles
;
diagnostic imaging
;
metabolism
;
pathology
;
Humans
;
Iron-Sulfur Proteins
;
genetics
;
Magnetic Resonance Imaging
;
methods
;
Male
;
Middle Aged
;
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
;
diagnostic imaging
;
genetics
;
pathology
;
Muscle, Skeletal
;
diagnostic imaging
;
metabolism
;
pathology
;
Oxidoreductases Acting on CH-NH Group Donors
;
genetics
;
Retrospective Studies
;
Young Adult
5.Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer.
Young Sun KIM ; Hye Lim LEE ; Ki Bum LEE ; Joo Hun PARK ; Wou Young CHUNG ; Keu Sung LEE ; Seung Soo SHEEN ; Kwang Joo PARK ; Sung Chul HWANG
The Korean Journal of Internal Medicine 2011;26(3):304-313
BACKGROUND/AIMS: Oxidative stress results in protein oxidation and is implicated in carcinogenesis. Sulfiredoxin (Srx) is responsible for the enzymatic reversal of inactivated peroxiredoxin (Prx). Nuclear factor E2-related factor 2 (Nrf2) binds to antioxidant responsive elements and upregulates the expression of Srx and Prx during oxidative stress. We aimed to elucidate the biological functions and potential roles of Srx in lung cancer. METHODS: To study the roles of Srx and Prx III in lung cancer, we compared the protein levels of Nrf2, Prxs, thioredoxin, and Srx in 40 surgically resected human lung cancer tissues using immunoblot and immunohistochemical analyses. Transforming growth factor-beta1, tumor necrosis factor-alpha, and camptothecin treatment were used to examine Prx III inactivation in Mv1Lu mink lung epithelial cells and A549 lung cancer cells. RESULTS: Prx I and Prx III proteins were markedly overexpressed in lung cancer tissues. A significant increase in the oxidized form of a cysteine sulfhydryl at the catalytic site of Prxs was found in carcinogenic lung tissue compared to normal lung tissue. Densitometric analyses of immunoblot data revealed significant Srx expression, which was higher in squamous cell carcinoma tissue (60%, 12/20) than in adenocarcinoma (20%, 4/20). Also, Nrf2 was present in the nuclear compartment of cancer cells. CONCLUSIONS: Srx and Prx III proteins were markedly overexpressed in human squamous cell carcinoma, suggesting that these proteins may play a protective role against oxidative injury and compensate for the high rate of mitochondrial metabolism in lung cancer.
Adenocarcinoma/*enzymology/genetics/mortality/pathology
;
Animals
;
Antineoplastic Agents, Phytogenic/pharmacology
;
Blotting, Western
;
Camptothecin/pharmacology
;
Carcinoma, Squamous Cell/*enzymology/genetics/mortality/pathology
;
Cell Line, Tumor
;
Humans
;
Immunohistochemistry
;
Lung Neoplasms/*enzymology/genetics/mortality/pathology
;
Mink
;
NF-E2-Related Factor 2/*metabolism
;
Oxidoreductases Acting on Sulfur Group Donors/genetics/*metabolism
;
Peroxiredoxin III/*metabolism
;
Peroxiredoxins/metabolism
;
Prognosis
;
RNA Interference
;
Reactive Oxygen Species/metabolism
;
Transfection
;
Transforming Growth Factor beta1/metabolism
;
Tumor Necrosis Factor-alpha/metabolism
;
Up-Regulation